Unknown

Dataset Information

Plasma proteomics identify potential severity biomarkers from COVID-19 associated network.


ABSTRACT:

Purpose

Coronavirus disease 2019 (COVID-19) continues to threaten public health globally. Severe acute respiratory coronavirus type 2 (SARS-CoV-2) infection-dependent alterations in the host cell signaling network may unveil potential target proteins and pathways for therapeutic strategies. In this study, we aim to define early severity biomarkers and monitor altered pathways in the course of SARS-CoV-2 infection.

Experimental design

We systematically analyzed plasma proteomes of COVID-19 patients from Turkey by using mass spectrometry. Different severity grades (moderate, severe, and critical) and periods of disease (early, inflammatory, and recovery) are monitored. Significant alterations in protein expressions are used to reconstruct the COVID-19 associated network that w

SUBMITTER: Sahin AT 

PROVIDER: S-EPMC9874836 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature